# Niraparib With Abiraterone Acetate Plus Prednisone as First‐Line Therapy in Patients With Metastatic Castration‐Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/niraparib-with-abiraterone-acetate-plus-prednisone-as-first-line-therapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dingwei Ye,Marniza Saad,Ji Youl Lee,Wonho Jung,See‐Tong Pang,Lei Li,Howard Gurney,Gerhardt Attard,Kim N.,Suneel Mundle,Jianmin Zhuo,Anildeep Singh,Yun Lin,Shahneen Sandhu |
| Citations | 1 |
| DOI | 10.1111/iju.70455 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7155193853 |
| PMID | 42015879 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Anildeep Singh](https://scholariq.org/researchers/anildeep-singh/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.